Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Granuloma
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Lymphoproliferative Disorders » Granuloma
Description
A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. MeSH
Hierarchy View
Subtype Terms (10)
Angiolymphoid Hyperplasia with Eosinophilia
Churg-Strauss Syndrome
17 drugs (15 approved, 2 experimental)
Eosinophilic Granuloma
9 drugs (6 approved, 3 experimental)
Granuloma Annulare
3 approved drugs
Granuloma, Giant Cell
1 approved drug
Granuloma, Pyogenic
1 approved drug
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (6)
Other Experimental Indicated Drugs (4)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.